Text Size

Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations

Tavakoli S., Kari O.K., Turunen T., Lajunen T., Schmitt M., Lehtinen J., Tasaka F., Parkkila P., Ndika J., Viitala T., Alenius H., Urtti A., Subrizi A.


  • 2021
  • Molecular Pharmaceutics
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Technology

    Pharmacology

  • Affiliations

    Tavakoli, S., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Kari, O.K., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Turunen, T., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Lajunen, T., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Schmitt, M., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Lehtinen, J., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Tasaka, F., Pharmaceutics and Pharmacology Department, Global Rand, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma, Nara, 630-0101, Japan; Parkkila, P., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Ndika, J., Human Microbiome Research, Faculty of Medicine, University of Helsinki, P.O. Box 21, Helsinki, 00290, Finland; Viitala, T., Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Alenius, H., Human Microbiome Research, Faculty of Medicine, University of Helsinki, P.O. Box 21, Helsinki, 00290, Finland, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden; Urtti, A., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland, Institute of Chemistry, St. Petersburg State University, Petergof, Universitetskii pr. 26, St. Petersburg, 198504, Russian Federation, School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1, Kuopio, 70210, Finland; Subrizi, A., School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1, Kuopio, 70210, Finland

Related Publications

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective

Shi-van Wielink K., Dahlmann-Noor A., Li J., de Milliano T.W.L., Ernst F., Croci F., Sharma Y., Punekar Y.


Two-year prospective natural history study of EYS-associated retinitis pigmentosa using adaptive optics: the KEYS study

Masakazu H., Akiko M., Midori Y., Elena G.-S., Shohei K., Satoshi Y., Yuki T., Masanao T., Shuhei K., Yasuhiko H., Yasuo K., Kiyoko G.


Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study

Taniguchi M, Togashi Y, Yokota S, Hiraoka M, Kitahata S, Nakamura N, Yamamoto M, Mandai M, Gocho K, Toshimori M, Hirami Y, Gomi F, Kurimoto Y, Maeda A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022